GGINX | TOLLX | GGINX / TOLLX | |
Total Expense Ratio | 0.98 | 1.26 | 78% |
Annual Report Gross Expense Ratio | 1.24 | 1.39 | 89% |
Fund Existence | 9 years | 17 years | - |
Gain YTD | 6.739 | 6.788 | 99% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 99.1M | 867M | 11% |
Annual Yield % from dividends | 2.18 | 2.03 | 107% |
Returns for 1 year | 10.43 | 16.22 | 64% |
Returns for 3 years | -3.76 | -8.25 | 46% |
Returns for 5 years | 25.05 | 20.99 | 119% |
Returns for 10 years | N/A | 26.47 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 16.48 | 0.08 | +0.49% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
FLCO | 21.04 | 0.09 | +0.45% |
Franklin Investment Grade Corporate ETF | |||
FLRG | 32.02 | 0.02 | +0.06% |
Fidelity U.S. Multifactor ETF | |||
XJUL | 34.55 | -0.09 | -0.26% |
FT Vest U.S. Eq Enh & ModBufETF-Jul | |||
DFLV | 28.46 | -0.12 | -0.42% |
Dimensional US Large Cap Value ETF |